mRNA |
paclitaxel |
CTRPv2 |
pan-cancer |
AAC |
-0.056 |
0.1 |
mRNA |
BRD-K55473186 |
CTRPv2 |
pan-cancer |
AAC |
0.081 |
0.1 |
mRNA |
FQI-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.08 |
0.1 |
mRNA |
BRD-K58730230 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.1 |
mRNA |
OSI-027 |
CTRPv2 |
pan-cancer |
AAC |
-0.059 |
0.1 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.057 |
0.1 |
mRNA |
IPR-456 |
CTRPv2 |
pan-cancer |
AAC |
-0.064 |
0.1 |
mRNA |
PF-3758309 |
CTRPv2 |
pan-cancer |
AAC |
-0.074 |
0.1 |
mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.059 |
0.1 |
mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.063 |
0.1 |